Partnering

Vectura specialises in the development of inhaled therapies, principally for the treatment of respiratory diseases.

Vectura develops products in-house and welcomes the opportunity to work in collaboration with partners, to out-license its products with larger markets to major pharmaceutical companies and to in-license molecules for development or co-development with partners.

Vectura also out-licenses its proprietary device and formulation technologies to other companies developing inhaled pharmaceuticals on a non-exclusive basis where the resulting license will generate significant value.

Please use this section of the website to investigate partnering opportunities with Vectura.

Licensing and collaboration thumbnail Licensing and collaboration Information about out-licensing opportunities for Vectura’s products and technologies and in-licensing or collaboration for product development.
More
Current partnerships thumbnail Current partnerships Information about some of Vectura’s current partnerships.
More
Meet us thumbnail Meet us Information about where and how to meet Vectura.
More
Partnering

Product pipeline For details about Vectura’s products in pre-clinical and clinical development.
More

Proprietary technologies For information about Vectura’s proprietary devices and formulation technologies.
More

Product development strategy To learn how Vectura develops inhaled pharmaceuticals.
More